AI Simulations Aim to Predict Drug Trial Failures
Artificial intelligence is emerging as a potential tool to help pharmaceutical companies predict whether experimental drugs are likely to succeed before costly human trials. Novartis shares fell 11% after its late-stage trial of experimental...